|
2021 Journal Article Coronary 18F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndromeMajeed, Kamran, Bellinge, Jamie W., Butcher, Steele C., Alcock, Richard, Spiro, Jon, Playford, David, Hillis, Graham S., Newby, David E., Mori, Trevor A., Francis, Roslyn and Schultz, Carl J. (2021). Coronary 18F-sodium fluoride PET detects high-risk plaque features on optical coherence tomography and CT-angiography in patients with acute coronary syndrome. Atherosclerosis, 319, 142-148. doi: 10.1016/j.atherosclerosis.2020.12.010 |
|
2020 Journal Article Re: Prostate-Specific Membrane Antigen PET-CT in Patients with High-Risk Prostate Cancer before Curative-Intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multicentre StudyHofman, M. S., Lawrentschuk, N., Francis, R. J., Tang, C., Vela, I., Thomas, P., Rutherford, N., Martin, J. M., Frydenberg, M., Shakher, R., Wong, L. M., Taubman, K., Lee, S. T., Hsiao, E., Roach, P., Nottage, M., Kirkwood, I., Hayne, D., Link, E., Marusic, P., Matera, A., Herschtal, A., Iravani, A., Hicks, R. J., Williams, S., Murphy, D. G. and Taneja, Samir S. (2020). Re: Prostate-Specific Membrane Antigen PET-CT in Patients with High-Risk Prostate Cancer before Curative-Intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomised, Multicentre Study. Journal of Urology, 204 (4), 878-879. doi: 10.1097/JU.0000000000001220.01 |
|
2020 Journal Article Coronary artery 18F-NaF PET analysis with the use of an elastic motion correction softwareBellinge, Jamie W., Majeed, Kamran, Carr, Stuart S., Jones, Judson, Hong, Inki, Francis, Roslyn J. and Schultz, Carl J. (2020). Coronary artery 18F-NaF PET analysis with the use of an elastic motion correction software. Journal of Nuclear Cardiology, 27 (3), 952-961. doi: 10.1007/s12350-018-01587-7 |
|
2020 Journal Article 3-year freedom from progression following 68GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy: results of a prospective multi-center trialEmmett, Louise, Tang, Reuben, Nandurkar, Rohan H., Hruby, George, Roach, Paul J., Watts, Jo Anne, Cusick, Thomas, Kneebone, Andrew, Ho, Bao, Chan, Lyn, van Leeuwen, Pim, Scheltema, Matthijs, Nguyen, Andrew, Yin, Charlotte, Scott, Andrew, Tang, Colin, McCarthy, Michael, Fullard, Karen, Roberts, Matthew, Francis, Roslyn and Stricker, Phillip (2020). 3-year freedom from progression following 68GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy: results of a prospective multi-center trial. The Journal of Nuclear Medicine, 61 (6), 866-872. doi: 10.2967/jnumed.119.235028 |
|
2020 Journal Article Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre studyHofman, Michael S., Lawrentschuk, Nathan, Francis, Roslyn J., Tang, Colin, Vela, Ian, Thomas, Paul, Rutherford, Natalie, Martin, Jarad M., Frydenberg, Mark, Shakher, Ramdave, Wong, Lih-Ming, Taubman, Kim, Ting Lee, Sze, Hsiao, Edward, Roach, Paul, Nottage, Michelle, Kirkwood, Ian, Hayne, Dickon, Link, Emma, Marusic, Petra, Matera, Anetta, Herschtal, Alan, Iravani, Amir, Hicks, Rodney J., Williams, Scott and Murphy, Declan G. (2020). Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. The Lancet, 395 (10231), 1208-1216. doi: 10.1016/S0140-6736(20)30314-7 |
|
2020 Journal Article Baseline and post-treatment 18F-fluorocholine PET/CT predicts outcomes in hepatocellular carcinoma following locoregional therapyWallace, Michael C., Sek, Kenny, Francis, Roslyn J., Samuelson, Shaun, Ferguson, John, Tibballs, Jonathan, Asad, Ali, Preen, David B., MacQuillan, Gerry, Garas, George, Adams, Leon A. and Jeffrey, Gary P. (2020). Baseline and post-treatment 18F-fluorocholine PET/CT predicts outcomes in hepatocellular carcinoma following locoregional therapy. Digestive Diseases and Sciences, 65 (2), 647-657. doi: 10.1007/s10620-019-05781-6 |
|
2019 Journal Article TheraP: a randomized phase 2 trial of 177Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)Hofman, Michael S., Emmett, Louise, Violet, John, Y. Zhang, Alison, Lawrence, Nicola J., Stockler, Martin, Francis, Roslyn J., Iravani, Amir, Williams, Scott, Azad, Arun, Martin, Andrew, McJannett, Margaret and Davis, Ian D. (2019). TheraP: a randomized phase 2 trial of 177Lu-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603). BJU International, 124 (S1), 5-13. doi: 10.1111/bju.14876 |
|
2019 Conference Publication Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee – International Association for the Study of Lung Cancer – Mesothelioma Applied Research Foundation Clinical Trials Planning MeetingGill, Ritu R., Tsao, Anne S., Kindler, Hedy L., Richards, William G, Armato, Samuel G., Francis, Roslyn J., Gomez, Daniel R., Dahlberg, Suzanne, Rimner, Andreas, Simone, Charles B., de Perrot, Marc, Blumenthal, Gideon, Adjei, Alex A., Bueno, Raphael, Harpole, David H., Hesdorffer, Mary, Hirsch, Fred R., Pass, Harvey I., Yorke, Ellen, Rosenzweig, Kenneth, Burt, Bryan, Fennell, Dean A., Lindwasser, Wolf, Malik, Shakun, Peikert, Tobias, Mansfield, Aaron S., Salgia, Ravi, Yang, Haining, Rusch, Valerie W. and Nowak, Anna K. (2019). Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee – International Association for the Study of Lung Cancer – Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting. Elsevier Inc. doi: 10.1016/j.jtho.2019.08.012 |
|
2019 Journal Article Comparison between gallium-68 citrate positron emission tomography-computed tomography and gallium-67 citrate scintigraphy for infection imagingSegard, Tatiana, Morandeau, Laurence M. J. A., Dunne, Marina L., Robinson, James O., Murray, Ronan J., Geelhoed, Elizabeth A. and Francis, Roslyn J. (2019). Comparison between gallium-68 citrate positron emission tomography-computed tomography and gallium-67 citrate scintigraphy for infection imaging. Internal Medicine Journal, 49 (8), 1016-1022. doi: 10.1111/imj.14231 |
|
2019 Conference Publication Test-Retest Repeatability of 18F-FET PET in Small VolumesFerjancic, P., Ebert, M. A., Nowak, A. K., Francis, R. J. and Jeraj, R. (2019). Test-Retest Repeatability of 18F-FET PET in Small Volumes. Annual Meeting of the American-Association-of-Physicists-in-Medicine (AAPM), San Antonio Tx, Jul 14-18, 2019. HOBOKEN: WILEY. |
|
2019 Journal Article Imaging in pleural mesothelioma: a review of the 14th International Conference of the International Mesothelioma Interest GroupArmato, Samuel G., Francis, Roslyn J., Katz, Sharyn I., Ak, Guntulu, Opitz, Isabelle, Gudmundsson, Eyjolfur, Blyth, Kevin G. and Gupta, Ashish (2019). Imaging in pleural mesothelioma: a review of the 14th International Conference of the International Mesothelioma Interest Group. Lung Cancer, 130, 108-114. doi: 10.1016/j.lungcan.2018.11.033 |
|
2018 Journal Article In search of the vulnerable patient or the vulnerable plaque: 18F-sodium fluoride positron emission tomography for cardiovascular risk stratificationBellinge, Jamie W., Francis, Roslyn J., Majeed, Kamran, Watts, Gerald F. and Schultz, Carl J. (2018). In search of the vulnerable patient or the vulnerable plaque: 18F-sodium fluoride positron emission tomography for cardiovascular risk stratification. Journal of Nuclear Cardiology, 25 (5), 1774-1783. doi: 10.1007/s12350-018-1360-2 |
|
2018 Journal Article 68Ga-somatostatin analogue PET-CT: Analysis of costs and benefits in a public hospital settingSegard, Tatiana, Morandeau, Laurence M. J. A., Geelhoed, Elizabeth A and Francis, Roslyn J (2018). 68Ga-somatostatin analogue PET-CT: Analysis of costs and benefits in a public hospital setting. Journal of Medical Imaging and Radiation Oncology, 62 (1), 57-63. doi: 10.1111/1754-9485.12638 |
|
2018 Journal Article The impact of 68 Ga-PSMA PET/CT on management intent in prostate cancer: Results of an australian prospective multicenter studyRoach, Paul J., Francis, Roslyn, Emmett, Louise, Hsiao, Edward, Kneebone, Andrew, Hruby, George, Eade, Thomas, Nguyen, Quoc A., Thompson, Benjamin D., Cusick, Thomas, McCarthy, Michael, Tang, Colin, Ho, Bao, Stricker, Philip D. and Scott, Andrew M. (2018). The impact of 68 Ga-PSMA PET/CT on management intent in prostate cancer: Results of an australian prospective multicenter study . Journal of Nuclear Medicine, 59 (1), 82-88. doi: 10.2967/jnumed.117.197160 |
|
2017 Conference Publication Clinical management intent of Ga68 PSMA PET/CT imaging in prostate cancer: an Australian multicentre studyRoach, Paul, Francis, Roslyn, Emmett, Louise, McCarthy, Michael and Scott, Andrew (2017). Clinical management intent of Ga68 PSMA PET/CT imaging in prostate cancer: an Australian multicentre study. Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Denver, CO United States, 10-14 June 2017. Reston, VA United States: Society of Nuclear Medicine. |
|
2017 Conference Publication ATYPICAL FOR PROSTATE METASTASISCulleton, S. and Francis, R. (2017). ATYPICAL FOR PROSTATE METASTASIS. HOBOKEN: WILEY. |
|
2017 Conference Publication A RARE CASE OF MERKEL CELL CARCINOMA CARDIAC METASTASIS CAUSING CARDIAC TAMPONADE: REVIEW OF THE ROLE OF FDG PET IN MERKEL CELL CARCINOMADi Loreto, M., Millward, M. and Francis, R. (2017). A RARE CASE OF MERKEL CELL CARCINOMA CARDIAC METASTASIS CAUSING CARDIAC TAMPONADE: REVIEW OF THE ROLE OF FDG PET IN MERKEL CELL CARCINOMA. HOBOKEN: WILEY. |
|
2017 Journal Article Is FCH PET able to identify foci of infection superiorly to FDG PET?Hardy, Liesel Elisabeth, Hessamodini, Hannah, Wallace, Michael and Francis, Roslyn (2017). Is FCH PET able to identify foci of infection superiorly to FDG PET?. BMJ Case Reports, 2017 bcr-2017-219944, bcr-2017. doi: 10.1136/bcr-2017-219944 |
|
2016 Journal Article A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomyTan, Hendrick, Joseph, David, Loh, Nelson K., McCarthy, Michael, Leong, Eugene, Siew, Teck, Segard, Tatiana, Morandeau, Laurence, Trevenen, Michelle and Francis, Roslyn J. (2016). A pilot study of the utility of choline PET-CT in prostate cancer biochemical relapse following radical prostatectomy. Journal of Medical Imaging and Radiation Oncology, 60 (3), 374-381. doi: 10.1111/1754-9485.12455 |
|
2015 Journal Article A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesotheliomaNowak, A. K., Cook, A. M., McDonnell, A. M., Millward, M. J., Creaney, J., Francis, R. J., Hasani, A., Segal, A., Musk, A. W., Turlach, B. A., McCoy, M. J., Robinson, B. W.S. and Lake, R. A. (2015). A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma. Annals of Oncology, 26 (12), 2483-2490. doi: 10.1093/annonc/mdv387 |
